Literature DB >> 27010507

From amino acid sequence to bioactivity: The biomedical potential of antitumor peptides.

Aitor Blanco-Míguez1, Alberto Gutiérrez-Jácome1, Martín Pérez-Pérez1, Gael Pérez-Rodríguez1, Sandra Catalán-García2, Florentino Fdez-Riverola1, Anália Lourenço1,3, Borja Sánchez4.   

Abstract

Chemoprevention is the use of natural and/or synthetic substances to block, reverse, or retard the process of carcinogenesis. In this field, the use of antitumor peptides is of interest as, (i) these molecules are small in size, (ii) they show good cell diffusion and permeability, (iii) they affect one or more specific molecular pathways involved in carcinogenesis, and (iv) they are not usually genotoxic. We have checked the Web of Science Database (23/11/2015) in order to collect papers reporting on bioactive peptide (1691 registers), which was further filtered searching terms such as "antiproliferative," "antitumoral," or "apoptosis" among others. Works reporting the amino acid sequence of an antiproliferative peptide were kept (60 registers), and this was complemented with the peptides included in CancerPPD, an extensive resource for antiproliferative peptides and proteins. Peptides were grouped according to one of the following mechanism of action: inhibition of cell migration, inhibition of tumor angiogenesis, antioxidative mechanisms, inhibition of gene transcription/cell proliferation, induction of apoptosis, disorganization of tubulin structure, cytotoxicity, or unknown mechanisms. The main mechanisms of action of those antiproliferative peptides with known amino acid sequences are presented and finally, their potential clinical usefulness and future challenges on their application is discussed.
© 2016 The Protein Society.

Entities:  

Keywords:  antiproliferative; antitumoral; bioactive peptide; cancer; tumor

Mesh:

Substances:

Year:  2016        PMID: 27010507      PMCID: PMC4941772          DOI: 10.1002/pro.2927

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  72 in total

1.  Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.

Authors:  Masanori Noguchi; Gaku Arai; Kazumasa Matsumoto; Seiji Naito; Fukuko Moriya; Shigetaka Suekane; Nobukazu Komatsu; Satoko Matsueda; Tetsuro Sasada; Akira Yamada; Tatsuyuki Kakuma; Kyogo Itoh
Journal:  Cancer Immunol Immunother       Date:  2015-02-07       Impact factor: 6.968

2.  Conformational studies of antimetastatic laminin-1 derived peptides in different solvent systems, using solution NMR spectroscopy.

Authors:  M Jaseja; V Copié; J Starkey
Journal:  J Pept Res       Date:  2003-01

3.  Antimicrobial activity of marine sponge Clathria indica (Dendy, 1889).

Authors:  S Ravichandran; S Wahidullah; L D'Souza; R M Anbuchezhian
Journal:  Bioorg Khim       Date:  2011 Jul-Aug

4.  A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer.

Authors:  Rebecca L Prue; Frank Vari; Kristen J Radford; Hui Tong; Melinda Y Hardy; Rachael D'Rozario; Nigel J Waterhouse; Tony Rossetti; Robert Coleman; Christopher Tracey; Hans Goossen; Vinay Gounder; Georgina Crosbie; Sonia Hancock; Stephanie Diaz-Guilas; Paul Mainwaring; Peter Swindle; Derek N J Hart
Journal:  J Immunother       Date:  2015 Feb-Mar       Impact factor: 4.456

5.  Peptaibols from two unidentified fungi of the order Hypocreales with cytotoxic, antibiotic, and anthelmintic activities.

Authors:  Sloan Ayers; Brandie M Ehrmann; Audrey F Adcock; David J Kroll; Esperanza J Carcache de Blanco; Qi Shen; Steven M Swanson; Joseph O Falkinham; Mansukh C Wani; Sheila M Mitchell; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Pept Sci       Date:  2012-06-29       Impact factor: 1.905

6.  Antineoplastic agents, 325. Isolation and structure of the human cancer cell growth inhibitory cyclic octapeptides phakellistatin 10 and 11 from Phakellia sp.

Authors:  G R Pettit; R Tan; Y Ichihara; M D Williams; D L Doubek; L P Tackett; J M Schmidt; R L Cerny; M R Boyd; J N Hooper
Journal:  J Nat Prod       Date:  1995-06       Impact factor: 4.050

7.  Recombinant endostatin forms amyloid fibrils that bind and are cytotoxic to murine neuroblastoma cells in vitro.

Authors:  Onno Kranenburg; Loes M J Kroon-Batenburg; Arie Reijerkerk; Ya-Ping Wu; Emile E Voest; Martijn F B G Gebbink
Journal:  FEBS Lett       Date:  2003-03-27       Impact factor: 4.124

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Expression and purification of bioactive high-purity recombinant mouse SPP1 in Escherichia coli.

Authors:  Yunsheng Yuan; Xiyuan Zhang; Shunyan Weng; Wen Guan; Di Xiang; Jin Gao; Jingjing Li; Wei Han; Yan Yu
Journal:  Appl Biochem Biotechnol       Date:  2014-03-25       Impact factor: 2.926

10.  Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer.

Authors:  Masato Matsuyama; H Ishii; J Furuse; S Ohkawa; H Maguchi; N Mizuno; T Yamaguchi; T Ioka; T Ajiki; M Ikeda; K Hakamada; M Yamamoto; H Yamaue; K Eguchi; W Ichikawa; M Miyazaki; Y Ohashi; Y Sasaki
Journal:  Invest New Drugs       Date:  2014-12-13       Impact factor: 3.850

View more
  12 in total

1.  In Silico Screening of the Human Gut Metaproteome Identifies Th17-Promoting Peptides Encrypted in Proteins of Commensal Bacteria.

Authors:  Claudio Hidalgo-Cantabrana; Marco A Moro-García; Aitor Blanco-Míguez; Florentino Fdez-Riverola; Anália Lourenço; Rebeca Alonso-Arias; Borja Sánchez
Journal:  Front Microbiol       Date:  2017-09-08       Impact factor: 5.640

Review 2.  Bioactive Peptide of Marine Origin for the Prevention and Treatment of Non-Communicable Diseases.

Authors:  Ratih Pangestuti; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2017-03-09       Impact factor: 5.118

Review 3.  Evaluation of the use of therapeutic peptides for cancer treatment.

Authors:  Susan Marqus; Elena Pirogova; Terrence J Piva
Journal:  J Biomed Sci       Date:  2017-03-21       Impact factor: 8.410

4.  Silkworm Pupa Protein Hydrolysate Induces Mitochondria-Dependent Apoptosis and S Phase Cell Cycle Arrest in Human Gastric Cancer SGC-7901 Cells.

Authors:  Xiaotong Li; Hongqing Xie; Yajie Chen; Mingzi Lang; Yuyin Chen; Liangen Shi
Journal:  Int J Mol Sci       Date:  2018-03-28       Impact factor: 5.923

5.  Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.

Authors:  Tomasz Kostrzewa; Kamlesh K Sahu; Magdalena Gorska-Ponikowska; Jack A Tuszynski; Alicja Kuban-Jankowska
Journal:  Drug Des Devel Ther       Date:  2018-12-05       Impact factor: 4.162

6.  Chiral Pyridine-3,5-bis- (L-phenylalaninyl-L-leucinyl) Schiff Base Peptides as Potential Anticancer Agents: Design, Synthesis, and Molecular Docking Studies Targeting Lactate Dehydrogenase-A.

Authors:  Abd El-Galil E Amr; Randa E Abdel Mageid; Mohamed El-Naggar; Ahmed M Naglah; Eman S Nossier; Elsayed A Elsayed
Journal:  Molecules       Date:  2020-02-29       Impact factor: 4.411

Review 7.  Recent Advances in Small Peptides of Marine Origin in Cancer Therapy.

Authors:  Qi-Ting Zhang; Ze-Dong Liu; Ze Wang; Tao Wang; Nan Wang; Ning Wang; Bin Zhang; Yu-Fen Zhao
Journal:  Mar Drugs       Date:  2021-02-19       Impact factor: 5.118

Review 8.  Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides.

Authors:  Hee Kyoung Kang; Moon-Chang Choi; Chang Ho Seo; Yoonkyung Park
Journal:  Int J Mol Sci       Date:  2018-03-20       Impact factor: 5.923

9.  A Potential Antineoplastic Peptide of Human Prostate Cancer Cells Derived from the Lesser Spotted Dogfish (Scyliorhinus canicula L.).

Authors:  Adrien Bosseboeuf; Amandine Baron; Elise Duval; Aude Gautier; Pascal Sourdaine; Pierrick Auvray
Journal:  Mar Drugs       Date:  2019-10-16       Impact factor: 5.118

10.  K092A and K092B, Two Peptides Isolated from the Dogfish (Scyliorhinus canicula L.), with Potential Antineoplastic Activity Against Human Prostate and Breast Cancer Cells.

Authors:  Adrien Bosseboeuf; Amandine Baron; Elise Duval; Aude Gautier; Pascal Sourdaine; Pierrick Auvray
Journal:  Mar Drugs       Date:  2019-11-28       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.